Hepatoma-derived growth factor expression as a prognostic marker in cervical cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Obstet Gynecol. Feb 10, 2015; 4(1): 16-23
Published online Feb 10, 2015. doi: 10.5317/wjog.v4.i1.16

Table 3 Multivariate analysis of overall survival with clinicopathological factors in uterine cervical cancer patients

Factor	Category	χ²value	P value
Histological differentiation	1: Keratinized and nonkeratinized squamous cell carcinoma	0.51	0.474
Histological differentiation	0: Adenosquamous carcinoma
Vascular permeation	1: Absent	0.16	0.686
Vascular permeation	0: Present
Depth of invasion (pT)-A	1: T1	1.19	0.275
Depth of invasion (pT)-A	0: T2-4
Depth of invasion (pT)-B	1: T1 and 2	3.06	0.0801
Depth of invasion (pT)-B	0: T3 and 4
Lymph node metastasis (pN)	1: Absent	5.43	0.0197
Lymph node metastasis (pN)	0: Present
Hepatoma-derived growth factor expression	1: Level 0 and 1	5.94	0.0148
Hepatoma-derived growth factor expression	0: Level 2

Citation: Song M, Tomoeda M, Jin YF, Kubo C, Yoshizawa H, Kitamura M, Nagata S, Ohta Y, Kamiura S, Nakamura H, Tomita Y. Hepatoma-derived growth factor expression as a prognostic marker in cervical cancer. World J Obstet Gynecol 2015; 4(1): 16-23
URL: https://www.wjgnet.com/2218-6220/full/v4/i1/16.htm
DOI: https://dx.doi.org/10.5317/wjog.v4.i1.16

Song M, Tomoeda M, Jin YF, Kubo C, Yoshizawa H, Kitamura M, Nagata S, Ohta Y, Kamiura S, Nakamura H, Tomita Y. Hepatoma-derived growth factor expression as a prognostic marker in cervical cancer. World J Obstet Gynecol 2015; 4(1): 16-23 [DOI: 10.5317/wjog.v4.i1.16]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.